Effects of Health Care Payment Models on Physician Practice in the United States: Follow-Up Study

2018 ◽  
Author(s):  
Mark Friedberg ◽  
Peggy Chen ◽  
Molly Simmons ◽  
Tisamarie Sherry ◽  
Peter Mendel ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
The United States ◽  
Physician Practice ◽  
Follow Up Study ◽  
Health Care Payment ◽  
Payment Models

scholarly journals Effects of Health Care Payment Models on Physician Practice in the United States

10.7249/rr869 ◽  
2015 ◽  
Author(s):  
Mark Friedberg ◽  
Peggy Chen ◽  
Chapin White ◽  
Olivia Jung ◽  
Laura Raaen ◽  
...  
Keyword(s):  
United States ◽  
Health Care ◽  
The United States ◽  
Physician Practice ◽  
Health Care Payment ◽  
Payment Models

scholarly journals Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States

BMJ ◽  
1996 ◽  
Vol 313 (7049) ◽  
pp. 84-90 ◽  
Author(s):  
A. Ascherio ◽  
E. B Rimm ◽  
E. L Giovannucci ◽  
D. Spiegelman ◽  
M. Stampfer ◽  
...  
Keyword(s):  
United States ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Dietary Fat ◽  
The United States ◽  
Follow Up Study

Experience and Reason: Twenty-Year Follow-Up of Protective Immunity of the Oka Strain Live Varicella Vaccine

PEDIATRICS ◽  
1994 ◽  
Vol 94 (4) ◽  
pp. 524-526
Author(s):  
Yoshizo Asano ◽  
Sadao Suga ◽  
Tetsushi Yoshikawa ◽  
Ikuko Kobayashi ◽  
Takehiko Yazaki ◽  
...  
Keyword(s):  
United States ◽  
Clinical Trials ◽  
Protective Immunity ◽  
Protective Efficacy ◽  
Varicella Vaccine ◽  
The United States ◽  
Follow Up Study ◽  
Waning Immunity

Since the first report on the development of a live attenuated varicella vaccine in 1974, the vaccine has been studied extensively, with largely favorable results, in both healthy and leukemic children. It is now licensed in Japan, Korea, and some European countries, and is being considered for licensure in the United States. Although various clinical trials have established the safety, immunogenicity, and the efficacy of the vaccine, concern has been expressed that waning immunity in the vaccine recipients might allow the occurrence of more severe varicella later in life. We show data relevant to this concern on the approximately 20-year follow-up study of the vaccine recipients; this work further extends the experience of a long-term protective efficacy of the vaccine.

Building Personalized Cancer Follow-up Care Pathways in the United States: Lessons Learned From Implementation in England, Northern Ireland, and Australia

2019 ◽  
pp. 625-639 ◽  
Author(s):  
Catherine M. Alfano ◽  
Michael Jefford ◽  
Jane Maher ◽  
Sarah A. Birken ◽  
Deborah K. Mayer
Keyword(s):  
United States ◽  
Health Care ◽  
Northern Ireland ◽  
Health Care System ◽  
The United States ◽  
Lessons Learned ◽  
Care Pathways ◽  
Follow Up Care ◽  
Care System

There is a global need to transform cancer follow-up care to address the needs of cancer survivors while efficiently using the health care system to limit the effects of provider shortages, gaps in provider knowledge, and already overburdened clinics; improve the mental health of clinicians; and limit costs to health care systems and patients. England, Northern Ireland, and Australia are implementing an approach that triages patients to personalized follow-up care pathways depending on the types and levels of resources needed for patients’ long-term care that has been shown to meet patients’ needs, more efficiently use the health care system, and reduce costs. This article discusses lessons learned from these implementation efforts, identifying the necessary components of these care models and barriers and facilitators to implementation of this care. Specifically, the United States and other countries looking to transform follow-up care should consider how to develop six key principles of this care: algorithms to triage patients to pathways; methods to assess patient issues to guide care; remote monitoring systems; methods to support patients in self-management; ways to coordinate care and information exchange between oncology, primary care, specialists, and patients; and methods to engage all stakeholders and secure their ongoing buy-in. Next steps to advance this work in the United States are discussed.

Sign in / Sign up

Export Citation Format

Share Document